Wayne M. Morrison
Geen lopende functies
Profiel
Wayne M.
Morrison served as President, CEO, CFO, Secretary & Treasurer at Nord Resources Corp.
from 2011 to 2014.
Prior to that, he was Vice President-Finance & Administration at AmpliMed Corp.
from 2005 to 2007, Chief Financial Officer & Vice President at Fastrac 24 from 2002 to 2004, and President at Par One Golf Ventures from 1997 to 2002.
Morrison earned an undergraduate degree from the University of Delaware and an MBA from Kenan-Flagler Business School.
Eerdere bekende functies van Wayne M. Morrison
Bedrijven | Functie | Einde |
---|---|---|
AmpliMed Corp.
AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Financieel Directeur/CFO | 01-12-2007 |
Fastrac 24/7 Corp. | Financieel Directeur/CFO | 01-10-2004 |
Par One Golf Ventures | President | 01-01-2002 |
NORD RESOURCES CORPORATION | Algemeen Directeur | - |
Opleiding van Wayne M. Morrison
University of Delaware | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Nord Resources Corp.
Nord Resources Corp. Other Metals/MineralsNon-Energy Minerals Nord Resources Corp. explores, develops and operates mineral properties. The company was founded on June 18, 1971 and is headquartered in Tucson, AZ. | Non-Energy Minerals |
AmpliMed Corp.
AmpliMed Corp. Pharmaceuticals: MajorHealth Technology AmpliMed Corp. develops and manufactures drugs to treat cancer. Its products include amplimexon, amplizone and benzimidazole series. The firm is focused on the development of small-molecule oncology drugs with novel mechanisms of action. The company was founded by Evan M. Hersh, David S. Alberts, Robert Thomas Dorr and William A. Remers in 1989 and is headquartered in Tucson, AZ. | Health Technology |
Fastrac 24/7 Corp. | |
Par One Golf Ventures |